| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30037643 | HIV | ENSG00000184990.13 | protein_coding | SIVA1 | No | No | 10572 | O15304 |
| TVIS30037644 | HIV | ENSG00000184990.13 | protein_coding | SIVA1 | No | No | 10572 | O15304 |
| TVIS30037645 | HIV | ENSG00000184990.13 | protein_coding | SIVA1 | No | No | 10572 | O15304 |
| TVIS30037646 | HIV | ENSG00000184990.13 | protein_coding | SIVA1 | No | No | 10572 | O15304 |
| TVIS30037647 | HIV | ENSG00000184990.13 | protein_coding | SIVA1 | No | No | 10572 | O15304 |
| TVIS30037648 | HIV | ENSG00000184990.13 | protein_coding | SIVA1 | No | No | 10572 | O15304 |
| TVIS30037649 | HIV | ENSG00000184990.13 | protein_coding | SIVA1 | No | No | 10572 | O15304 |
| TVIS30037650 | HIV | ENSG00000184990.13 | protein_coding | SIVA1 | No | No | 10572 | O15304 |
| TVIS30037651 | HIV | ENSG00000184990.13 | protein_coding | SIVA1 | No | No | 10572 | O15304 |
| TVIS30037652 | HIV | ENSG00000184990.13 | protein_coding | SIVA1 | No | No | 10572 | O15304 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | SIVA1 |
|---|---|
| DrugBank ID | DB01593 |
| Drug Name | Zinc |
| Target ID | BE0005834 |
| UniProt ID | O15304 |
| Regulation Type | |
| PubMed IDs | 16683188 |
| Citations | Nestler M, Martin U, Hortschansky P, Saluz HP, Henke A, Munder T: The zinc containing pro-apoptotic protein siva interacts with the peroxisomal membrane protein pmp22. Mol Cell Biochem. 2006 Jul;287(1-2):147-55. Epub 2006 May 9. |
| Groups | Approved; Investigational |
| Direct Classification | Homogeneous transition metal compounds |
| SMILES | [Zn] |
| Pathways | Dihydropyrimidinase Deficiency; Rofecoxib Action Pathway; Losartan Action Pathway; AICA-Ribosiduria; Canavan Disease; Quinapril Action Pathway; Alkaptonuria; Eprosartan Action Pathway; gamma-Glutamyltransferase Deficiency; Pterine Biosynthesis; Sulindac Action Pathway; Rescinnamine Action Pathway; Piroxicam Action Pathway; Nabumetone Action Pathway; 2-Hydroxyglutric Aciduria (D and L Form); beta-Ureidopropionase Deficiency; Vitamin B6 Metabolism; Retinol Metabolism; Valsartan Action Pathway; Valdecoxib Action Pathway; Irbesartan Action Pathway; Adenosine Deaminase Deficiency; Hawkinsinuria; Methionine Metabolism; Ramipril Action Pathway; Benazepril Action Pathway; beta-Alanine Metabolism; Aspartate Metabolism; Diclofenac Action Pathway; Galactosemia |
| PharmGKB | PA451956 |
| ChEMBL | CHEMBL1201279 |
